安全药理学
医学
重症监护医学
药物开发
药理学
药品
临床前试验
风险评估
风险分析(工程)
毒理
临床药理学
相关性(法律)
人类使用
梅德林
安全概况
生物信息学
作者
Brett R. Winters,Quinn Kilgus,James R. Turk,Simon Authier,Michael K. Pugsley
标识
DOI:10.1177/10915818261501932
摘要
Minipigs are recognized as a relevant non-rodent species for nonclinical safety assessment in drug development, although their use remains considerably less common than that of dogs and non-human primates. Historically cited barriers to broader adoption have included increased test article requirements due to their larger size, limited historical control data, technical challenges, and limited experience with their use in nonclinical safety assessment. However, some of these limitations have been mitigated in recent years. While minipigs are most often used for dermally administered drugs due to similarities in skin structure, they are also considered a highly relevant model for cardiovascular research due to similarities in anatomy and physiology with the human cardiovascular system. In this review, we evaluate the advantages and limitations of using minipigs in nonclinical safety assessment for predicting human cardiovascular effects. We summarize current knowledge of porcine cardiovascular anatomy, electrophysiology, hemodynamics, and pharmacokinetics, and discuss how these parameters influence the translational relevance of the minipig model.
科研通智能强力驱动
Strongly Powered by AbleSci AI